Risk of Severe COVID-19 Up Among Those With Diabetes
Risk for severe COVID-19 similar among those with type 1 and type 2 diabetes
Risk for severe COVID-19 similar among those with type 1 and type 2 diabetes
Loneliness is a risk factor for type 2 diabetes.
Many common skin disorders may not simply be independent symptoms, but they may represent the first clinical signs of diabetes mellitus.
EyeArt is the first FDA-cleared AI technology for autonomous detection of more than mild diabetic retinopathy and vision-threatening diabetic retinopathy.
This study found that diabetic patients with COVID-19 had lower lymphocyte counts and hospital stays.
The FDA has approved Qutenza® (capsaicin 8% patch; Averitas Pharma) for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet.
In individuals with prediabetes, 12 weeks of cinnamon supplementation improved fasting plasma glucose and glucose tolerance.
Patients with diabetes admitted to a tertiary care center for diabetic foot ulceration during the COVID-19 lockdown in Italy had a more than threefold risk for amputation versus patients seen in 2019.
Vitamin D supplements may significantly improve neuropathic symptoms, including pain and quality of life.
Deep learning has shown substantial promise to date in automated image analysis towards the accurate diagnosis of diabetic retinopathy.